Stock Fundamentals

Company Information

Company Name
BioLineRx Ltd
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US09071M3043
CIK: 0001498403
CUSIP: 09071M205
Currency: USD
Full Time Employees: 28
Phone: 972 8 642 9100
Fiscal Year End: December
IPO Date: Jul 25, 2011
Description:

BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.

Address:

Modi?in Technology Park, Hevel Modi'in, Israel, 7177871

Directors & Officers

Name Title Year Born
Mr. Philip A. Serlin CPA, M.B.A. Chief Executive Officer 1960
Ms. Mali Zeevi CPA Chief Financial Officer 1976
Dr. Ella Sorani Ph.D. Chief Development Officer 1968
Mr. John Lacey Head of Corporate Communications & Investor Relations NA
Mr. Raziel Fried Treasurer & Budgetary Control Director NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Citadel Advisors Llc 10.02K Sep 30, 2025 0.23% $0.00 -32.99%
UBS Group AG 6.39K Sep 30, 2025 0.15% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 5.95K Sep 30, 2025 0.14% $0.00 285.81%
Rhumbline Advisers 3.07K Sep 30, 2025 0.07% $0.00 -28.19%
Wells Fargo & Co 1.75K Sep 30, 2025 0.04% $0.00 0.00%
BNP Paribas Arbitrage, SA 1.50K Dec 31, 2025 0.03% $0.00 0.00%
Goss Wealth Management LLC 107.00 Sep 30, 2025 0.00% $0.00 0.00%
Tower Research Capital LLC 39.00 Sep 30, 2025 0.00% $0.00 0.00%
Rockefeller Capital Management L.P. 12.00 Sep 30, 2025 0.00% $0.00 0.00%
Danske Bank A/S. 2.00 Sep 30, 2025 0.00% $0.00 0.00%
SBI Securities Co Ltd 2.00 Sep 30, 2025 0.00% $0.00 0.00%
Bank of America Corp 2.00 Sep 30, 2025 0.00% $0.00 0.00%
Advisor Group Holdings, Inc. 1.00 Sep 30, 2025 0.00% $0.00 0.00%
Susquehanna International Group, LLP 0.00 Sep 30, 2025 0.00% $0.00 -100.00%
SIMPLEX TRADING, LLC 0.00 Sep 30, 2025 0.00% $0.00 -100.00%
Citigroup Inc 0.00 Sep 30, 2025 0.00% $0.00 -100.00%
NATIONAL BANK OF CANADA /FI/ 0.00 Sep 30, 2025 0.00% $0.00 -100.00%
TWO SIGMA SECURITIES, LLC 0.00 Sep 30, 2025 0.00% $0.00 -100.00%
Fifth Third Bancorp 0.00 Sep 30, 2025 0.00% $0.00 -100.00%

Shares Statistics

Shares Outstanding: 4.26M
Shares Float: 2.45B
% Insiders: 399.50%
% Institutions: 107.90%
Short % Float: 4.42%

🏆 Top 10 Institutional Holders

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Citadel Advisors Llc 10.02K 0.23% ▼ 32.99% Sep 30, 2025
2 UBS Group AG 6.39K 0.15% ▲ 0.00% Sep 30, 2025
3 Morgan Stanley - Brokerage Accounts 5.95K 0.14% ▲ 285.81% Sep 30, 2025
4 Rhumbline Advisers 3.07K 0.07% ▼ 28.19% Sep 30, 2025
5 Wells Fargo & Co 1.75K 0.04% ▲ 0.00% Sep 30, 2025
6 BNP Paribas Arbitrage, SA 1.50K 0.03% ▲ 0.00% Dec 31, 2025
7 Goss Wealth Management LLC 107.00 0.00% ▲ 0.00% Sep 30, 2025
8 Tower Research Capital LLC 39.00 0.00% ▲ 0.00% Sep 30, 2025
9 Rockefeller Capital Management L.P. 12.00 0.00% ▲ 0.00% Sep 30, 2025
10 Danske Bank A/S. 2.00 0.00% ▲ 0.00% Sep 30, 2025

Valuation Metrics

Enterprise Value: $-1.33M
Trailing P/E: 0.00
Forward P/E: 93.46

Financial Highlights

Market Cap: $15.18M
EBITDA: $-10.83M
PEG Ratio: $0.20
Book Value: $0.01
Earnings/Share: $-6.00
Profit Margin: -45.34%
Operating Margin: -757.57%
ROA (TTM): -15.36%
ROE (TTM): -45.94%
Revenue (TTM): $17.25M
Revenue/Share (TTM): $6.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -94.40%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Download Financials (Excel)

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios (Yearly)

Financial Ratios (Quarterly)

Earnings History

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 1.76x 1.04x 0.65x -2.23x 3.56x
2023-12-31 1.10x 0.78x 0.79x -22.91x -0.18x
2022-12-31 4.87x 0.21x 0.33x -13.51x -0.37x
2021-12-31 5.91x 0.04x 0.16x -25.18x -0.12x
2020-12-31 2.15x 0.27x 0.53x -15.60x -0.22x
2019-12-31 2.36x 0.26x 0.38x -15.37x -0.38x
2018-12-31 4.74x 0.21x 0.27x -1,219.29x -0.40x
2017-12-31 7.49x 0.00x 0.13x -1,201.90x -0.01x
2016-12-31 9.86x 0.01x 0.10x -1,179.50x -0.02x
2015-12-31 15.34x 0.01x 0.07x -1,079.73x -0.03x
2014-12-31 12.10x 0.00x 0.12x -41.92x 0.00x
2013-12-31 6.15x 0.00x 0.41x -822.68x 0.00x
2012-12-31 3.45x 0.00x 0.38x -814.52x 0.00x
2011-12-31 4.02x 0.00x 0.23x -14.61x -0.01x
2010-12-31 6.59x 0.01x 0.15x 222.70x 0.05x
2009-12-31 3.57x 0.00x 0.26x N/A 0.00x
2008-12-31 2.75x 0.00x 0.32x N/A 0.00x

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about BLRX.US!